Global Cell Analysis Market – Industry Trends and Forecast to 2030

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Cell Analysis Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Jan 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Author : Sachin Pawar

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Global Cell Analysis Market

Market Size in USD Billion

CAGR :  % Diagram

Bar chart comparing the Global Cell Analysis Market size in 2022 - 18.41 and 2030 - 33.82, highlighting the projected market growth. USD 18.41 Billion USD 33.82 Billion 2022 2030
Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 18.41 Billion
Diagram Market Size (Forecast Year)
USD 33.82 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Danaher
  • Thermo Fisher Scientific Inc.
  • BD
  • General Electric
  • Merck KGaA AGilent TechnologiesInc

Global Cell Analysis Market, By Product (Flow Cytometry Products, Qpcr Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters, High-Content Screening Systems, Other Products),  Process (Cell Identification, Cell Viability, Cell Signalling Pathway/Signal Transduction, Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Cell Structure Study, Target Identification and Validation, Single-Cell Analysis), End User (Pharmaceutical and Biotechnology Companies and Contract Research Organizations (CROS), Hospitals and Diagnostic Laboratories, Research Institutes, Cell Culture Collection Repositories, Other End Users) – Industry Trends and Forecast to 2030.

Cell Analysis Market

Cell Analysis Market Analysis and Size

According to the American Cancer Society, cancer is the second leading cause of death in the United States, trailing only heart disease. According to cancer statistics, 1.9 million new cancer cases are expected in the United States in 2022. Thus, the rising prevalence of cancer, as well as the never-ending research and development in this field, are expected to have a positive impact on industry growth.

Data Bridge Market Research analyses that the cell analysis market which is USD 18.41 billion in 2022, is expected to reach USD 33.82 billion by 2030, at a CAGR of 7.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Cell Analysis Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product (Flow Cytometry Products, Qpcr Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters, High-Content Screening Systems, Other Products),  Process (Cell Identification, Cell Viability, Cell Signalling Pathway/Signal Transduction, Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Cell Structure Study, Target Identification and Validation, Single-Cell Analysis), End User (Pharmaceutical and Biotechnology Companies and Contract Research Organizations (CROS), Hospitals and Diagnostic Laboratories, Research Institutes, Cell Culture Collection Repositories, Other End Users)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Danaher (U.S.), Thermo Fisher Scientific Inc. (U.S.), BD (U.S.), General Electric (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc (U.S.), Olympus Corporation (Japan), Promega Corporation (U.S.), PerkinElmer Inc. (U.S.), Tecan Trading AG (Switzerland), Miltenyi Biotec (Germany), Carl Zeiss AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), BioStatus Limited (U.K.), NanoCellect Biomedical (U.S.)

Market Opportunities

  • Technological advancements in cell analysis

Market Definition

Cell analysis is an umbrella term for a wide range of technologies used to study a cell's genetic and phenotypical characteristics. Its goal is to gain insights into the mechanisms of cellular functionality, which necessitates an understanding of cellular components such as DNA, RNA, protein content, and cellular metabolites. Cell analysis is commonly used to understand population heterogeneity, identify minority subpopulations of interest, and discover unique characteristics of individual cells. It also helps with gene and protein identification, epigenomics, and understanding the factors that govern cell health, proliferation, and death.

Cell Analysis Market Dynamics

Drivers

  • Growing demand for analytical tools

The increasing demand for analytical tools for innovative research and subsequent funding has resulted in the introduction of high-throughput equipment. Multiple innovations have led to this equipment incorporating features such as automation, high sensitivity, and accuracy, all of which aid in the analysis of scarce samples. For instance, Deepcell Inc., a U.S.-based company, received USD 73 million in funding in March 2022 to accelerate and commercialize its AI-powered single cell analysis platform. As a result, key players are significantly investing in developing solutions, resulting in a lucrative revenue generation opportunity in the coming years.

Opportunities

  • Technological advancements in cell analysis

The rising prevalence of chronic diseases and the development of advanced cancer therapies are driving technological advancements in cell analysis. For instance, Fluidigm Corporation, based in the United States, announced the launch of a REAP-seq (RNA expression and protein sequencing) platform that will aid researchers in understanding the mechanisms of cancer progression and immune response.

Restraints/Challenges

  • High cost associated with instruments

Large costs associated with the use of instruments and complex and time-consuming guidelines will be some of the constraints that will hamper the cell analysis during the forecast period. The greatest challenge to the market's growth will be a lack of skilled professionals.

This cell analysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cell analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In 2022, Lifebit, a big data company based in the United Kingdom, announced a partnership with Boehringer Ingelheim. The collaboration will use Lifebit's Cloud OS, the first federated genomics platform, to build a data analytics infrastructure for Boehringer. This infrastructure will collect disease insights from biobanks in order to develop medicines.
  • In 2021, SeqWell Inc. announced the release of the plexWell Single Cell Rapid Kit. The kit can be used for single-cell RNA sequencing as well as simplified NGS library preparation.

Global Cell Analysis Market Scope

The cell analysis market is segmented on the basis of product, process and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Flow Cytometry Products
  • Reagents and Consumables
  •  Instruments
  •  Accessories
  •  Software
  • Qpcr Products
  • Reagents and Consumables
  •  Instruments
  • Cell Microarrays
  • Consumables
  • Instruments
  • Microscopes
  • Electron Microscopes
  • Inverted Microscopes
  •  Stereo Microscopes
  •  Fluorescence and Confocal Microscopes
  •  Phase-Contrast Microscopes
  •  Near-Field Scanning Optical Microscopes
  • Other Microscopes
  • Spectrophotometers
  • Single-Mode Readers
  • Multi-Mode Readers
  • Cell Counters
  • Automated Cell Counters
  •  Hemocytometers
  • Manual Cell Counters
  • High-Content Screening Systems
  • Other Products

 Process

  • Cell Identification
  • Cell Viability
  • Cell Signalling Pathway/Signal Transduction
  • Cell Proliferation
  • Cell Counting and Quality Control
  • Cell Interaction
  • Cell Structure Study
  • Target Identification and Validation
  • Single-Cell Analysis

 End User

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROS)
  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Cell Culture Collection Repositories
  • Other End Users

Cell Analysis Market Regional Analysis/Insights

The cell analysis market is analyzed and market size insights and trends are provided by country, product, process and end user as referenced above.

The countries covered in the cell analysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cell analysis market because of the prevalence of the business environment, increased government investment in drug discovery, and an increase in the number of research activities in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The cell analysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cell analysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cell analysis market. The data is available for historic period 2011-2021.

Competitive Landscape and Cell Analysis Market Share Analysis

The cell analysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cell analysis market.

Some of the major players operating in the cell analysis market are:

  • Danaher (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • BD (U.S.)
  • General Electric (U.S.)
  • Merck KGaA (Germany)
  • Agilent Technologies, Inc (U.S.)
  • Olympus Corporation (Japan)
  • Promega Corporation (U.S.)
  • PerkinElmer Inc. (U.S.)
  • Tecan Trading AG (Switzerland)
  • Miltenyi Biotec (Germany)
  • Carl Zeiss AG (Germany)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Sysmex Corporation (Japan)
  • BioStatus Limited (U.K.)
  • NanoCellect Biomedical (U.S.)

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL CELL ANALYSIS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE CELL ANALYSIS SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 SALES VOLUME DATA

2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL CELL ANALYSIS MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 PESTEL ANALYSIS

5.2 PORTER’S FIVE FORCES MODEL

6 INDUSTRY INSIGHTS

6.1 MICRO AND MACRO ECONOMIC FACTORS

6.2 PENETRATION AND GROWTH PROSPECT MAPPING

6.3 KEY PRICING STRATEGIES

6.4 INTERVIEWS WITH SPECIALIST

6.5 ANALYIS AND RECOMMENDATION

7 INTELLECTUAL PROPERTY (IP) PORTFOLIO

7.1 PATENT QUALITY AND STRENGTH

7.2 PATENT FAMILIES

7.3 LICENSING AND COLLABORATIONS

7.4 COMPETITIVE LANDSCAPE

7.5 IP STRATEGY AND MANAGEMENT

7.6 OTHER

8 COST ANALYSIS BREAKDOWN

9 TECHNONLOGY ROADMAP

10 INNOVATION TRACKER AND STRATEGIC ANALYSIS

10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

10.1.1 JOINT VENTURES

10.1.2 MERGERS AND ACQUISITIONS

10.1.3 LICENSING AND PARTNERSHIP

10.1.4 TECHNOLOGY COLLABORATIONS

10.1.5 STRATEGIC DIVESTMENTS

10.2 NUMBER OF PRODUCTS IN DEVELOPMENT

10.3 STAGE OF DEVELOPMENT

10.4 TIMELINES AND MILESTONES

10.5 INNOVATION STRATEGIES AND METHODOLOGIES

10.6 RISK ASSESSMENT AND MITIGATION

10.7 MERGERS AND ACQUISITIONS

10.8 FUTURE OUTLOOK

11 REGULATORY COMPLIANCE

11.1 REGULATORY AUTHORITIES

11.2 REGULATORY CLASSIFICATIONS

11.2.1 CLASS I

11.2.2 CLASS II

11.2.3 CLASS III

11.3 REGULATORY SUBMISSIONS

11.4 INTERNATIONAL HARMONIZATION

11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

11.6 REGULATORY CHALLENGES AND STRATEGIES

12 PIPELINE ANALYSIS

12.1 CLINICAL TRIALS AND PHASE ANALYSIS

12.2 DRUG THERAPY PIPELINE

12.3 PHASE III CANDIDATES

12.4 PHASE II CANDIDATES

12.5 PHASE I CANDIDATES

12.6 OTHERS (PRE-CLINICAL AND RESEARCH)

TABLE 1 GLOBAL CLINICAL TRIAL MARKET FOR CELL ANALYSIS MARKET

Company Name Product Name

XX XX

XX XX

XX XX

XX XX

XX XX

XX XX

XX XX

Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews

TABLE 2 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE CELL ANALYSIS MARKET

Phase Number of Projects

Preclinical/Research Projects XX

Clinical Development XX

Phase I XX

Phase II XX

Phase III XX

U.S. Filed/Approved but Not Yet Marketed XX

Total XX

Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews

TABLE 3 DISTRIBUTION OF PROJECTS BY THERAPEUTIC AREA AND PHASE FOR CELL ANALYSIS MARKET

Therapeutic Area Preclinical/ Research Project

XX XX

XX XX

XX XX

XX XX

XX XX

Total Projects XX

Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews

TABLE 4 DISTRIBUTION OF PROJECTS BY SCIENTIFIC APPROACH AND PHASE FOR CELL ANALYSIS MARKET

Technology Preclinical/ Research Project

XX XX

XX XX

XX XX

XX XX

XX XX

Total Projects XX

Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews

FIGURE 1 TOP ENTITIES BASED ON R&D GLANCE FOR CELL ANALYSIS MARKET

Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews

13 REIMBURSEMENT FRAMEWORK

14 OPPUTUNITY MAP ANALYSIS

15 VALUE CHAIN ANALYSIS

16 HEALTHCARE ECONOMY

16.1 HEALTHCARE EXPENDITURE

16.2 CAPITAL EXPENDITURE

16.3 CAPEX TRENDS

16.4 CAPEX ALLOCATION

16.5 FUNDING SOURCES

16.6 INDUSTRY BENCHMARKS

16.7 GDP RATION IN OVERALL GDP

16.8 HEALTHCARE SYSTEM STRUCTURE

16.9 GOVERNMENT POLICIES

16.1 ECONOMIC DEVELOPMENT

17 GLOBAL CELL ANALYSIS MARKET, BY PRODUCT

17.1 OVERVIEW

17.2 INSTRUMENTS

17.2.1 BY TYPE

17.2.1.1. PCR

17.2.1.1.1. DIGITAL PCR

17.2.1.1.2. REAL-TIME PCR

17.2.1.2. FLOW CYTOMETERS

17.2.1.2.1. CELL-BASED FLOW CYTOMETRY

17.2.1.2.2. BEAD-BASED FLOW CYTOMETRY

17.2.1.3. MICROSCOPES

17.2.1.3.1. OPTICAL

17.2.1.3.1.1 UPRIGHT

17.2.1.3.1.2 INVERTED

17.2.1.3.1.3 STEREOMICROSCOPES

17.2.1.3.1.4 PHASE CONTRAST

17.2.1.3.1.5 FLUORESCENCE

17.2.1.3.1.6 CONFOCAL SCANNING

17.2.1.3.1.7 NEAR FIELD SCANNING

17.2.1.3.1.8 OTHER OPTICAL MICROSCOPES

17.2.1.3.2. ELECTRON

17.2.1.3.2.1 SCANNING ELECTRON

17.2.1.3.2.2 TRANSMISSION

17.2.1.3.3. SCANNING PROBE

17.2.1.3.4. OTHERS

17.2.1.4. SPECTROPHOTOMETERS

17.2.1.4.1. MOLECULAR SPECTROMETRY

17.2.1.4.1.1 VISIBLE AND ULTRAVIOLET SPECTROSCOPY

17.2.1.4.1.2 INFRARED SPECTROSCOPY

17.2.1.4.1.3 NUCLEAR MAGNETIC RESONANCE (NMR) SPECTROSCOPY

17.2.1.4.1.4 OTHERS

17.2.1.4.2. MASS SPECTROMETRY (MS)

17.2.1.4.2.1 MALDI-TOF

17.2.1.4.2.2 TRIPLE QUADRUPOLE

17.2.1.4.2.3 QUADRUPOLE-TRAP

17.2.1.4.2.4 HYBRID LINEAR ION TRAP ORBITRAP

17.2.1.4.2.5 QUADRUPOLE-ORBITRAP

17.2.1.4.3. ATOMIC SPECTROMETRY

17.2.1.5. HEMOCYTOMETERS

17.2.1.5.1. DISPOSABLE

17.2.1.5.2. REUSABLE

17.2.1.6. CELL COUNTERS

17.2.1.7. CELL SORTER

17.2.1.7.1. MAGNETIC-ACTIVATED CELL SORTING (MACS) SYSTEM

17.2.1.7.2. OTHERS

17.2.1.8. MICROFLUIDIC DEVICES.

17.2.1.9. INCUBATORS

17.2.1.10. BIOSAFETY CABINETS

17.2.1.11. CENTRIFUGE

17.2.1.12. OTHERS

17.2.2 BY MODE

17.2.2.1. AUTOMATIC

17.2.2.2. MANUAL

17.2.3 BY MODALITY

17.2.3.1. BENCHTOP

17.2.3.2. PORTABLES

17.2.3.3. STANDALONE

17.2.3.4. OTHERS

17.3 CONSUMABLES

17.3.1 REAGENTS & KITS

17.3.2 STAINS & DYES

17.3.3 PROBES

17.3.4 BUFFERS & MEDIA

17.3.5 STANDARDS & CONTROLS

17.3.6 CELL DISSOCIATION REAGENTS

17.3.7 GLASS SLIDES AND COVERSLIPS.

17.3.8 MICROPLATES

17.3.9 BEADS

17.3.10 DISPOSABLES

17.3.11 OTHERS

18 GLOBAL CELL ANALYSIS MARKET, BY PROCESS

18.1 CELL IDENTIFICATION

18.2 CELL VIABILITY

18.3 CELL SIGNALLING PATHWAY/SIGNAL TRANSDUCTION

18.4 CELL PROLIFERATION

18.5 CELL COUNTING AND QUALITY CONTROL

18.6 CELL INTERACTION

18.7 CELL STRUCTURE STUDY

18.8 TARGET IDENTIFICATION AND VALIDATION

18.9 SINGLE-CELL ANALYSIS

18.1 OTHERS

19 GLOBAL CELL ANALYSIS MARKET, BY TECHNIQUE

19.1 OVERVIEW

19.2 NEXT-GENERATION SEQUENCING

19.2.1 WHOLE GENOME SEQUENCING

19.2.2 TARGETED SEQUENCING & RESEQUENCING

19.2.3 OTHERS

19.3 FLOW CYTOMETRY

19.4 POLYMERASE CHAIN REACTION

19.5 MICROSCOPY

19.6 SPECTROMETRY

19.7 MICROARRAY

19.8 OTHERS

20 GLOBAL CELL ANALYSIS MARKET, BY CELL TYPE

20.1 OVERVIEW

20.2 HUMAN CELLS

20.2.1 PRIMARY CELLS

20.2.2 STEM CELLS

20.2.3 DIFFERENTIATED CELLS

20.2.4 TUMOR CELLS

20.3 ANIMAL CELLS

20.3.1 PRIMARY CELLS

20.3.2 STEM CELLS

20.3.3 DIFFERENTIATED CELLS

20.3.4 TUMOR CELLS

20.4 MICROBIAL CELLS

20.4.1 PRIMARY CELLS

20.4.2 STEM CELLS

20.4.3 DIFFERENTIATED CELLS

20.4.4 TUMOR CELLS

20.5 PLANT CELLS

21 GLOBAL CELL ANALYSIS MARKET, BY APPLICATION

21.1 OVERVIEW

21.2 RESEARCH APPLICATIONS

21.2.1 BY TYPE

21.2.1.1. STEM CELL RESEARCH

21.2.1.2. CANCER RESEARCH

21.2.1.2.1. LUNG CANCER

21.2.1.2.2. STOMACH CANCER

21.2.1.2.3. COLORECTAL CANCER

21.2.1.2.4. BREAST CANCER

21.2.1.2.5. PROSTATE CANCER

21.2.1.2.6. LIVER CANCER

21.2.1.2.7. ESOPHAGUS CANCER

21.2.1.2.8. CERVICAL CANCER

21.2.1.2.9. KIDNEY CANCER

21.2.1.2.10. BLADDER CANCER

21.2.1.2.11. OTHERS

21.2.1.3. DRUG DISCOVERY & DEVELOPMENT

21.2.1.4. IMMUNOLOGY RESEARCH

21.2.1.5. NEUROBIOLOGY RESEARCH

21.2.1.6. CELL BIOLOGY RESEARCH

21.2.2 BY PRODUCT

21.2.2.1. INSTRUMENTS

21.2.2.2. CONSUMBALES

21.3 CLINICAL APPLICATIONS

21.3.1 BY TYPE

21.3.1.1. DISEASE DIAGNOSIS

21.3.1.2. HEMATOLOGY

21.3.1.3. ONCOLOGY

21.3.1.4. INFECTIOUS DISEASES

21.3.1.5. CARDIOLOGY

21.3.1.6. OTHERS

21.3.2 BY PRODUCT

21.3.2.1. INSTRUMENTS

21.3.2.2. CONSUMBALES

21.4 INDUSTRIAL APPLICATIONS

21.4.1 BY TYPE

21.4.1.1. BIOPROCESSING

21.4.1.2. QUALITY CONTROL

21.4.1.3. ENVIRONMENTAL TESTING

21.4.2 BY PRODUCT

21.4.2.1. INSTRUMENTS

21.4.2.2. CONSUMBALES

21.5 OTHERS

22 GLOBAL CELL ANALYSIS MARKET, BY END USER

22.1 OVERVIEW

22.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

22.2.1 BY TYPE

22.2.1.1. SMALL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

22.2.1.2. MEDIUM PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

22.2.1.3. ARGE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

22.2.2 BY PRODUCT

22.2.2.1. INSTRUMENTS

22.2.2.2. CONSUMABLES

22.3 ACADEMIC & RESEARCH INSTITUTES

22.3.1 BY PRODUCT

22.3.1.1. INSTRUMENTS

22.3.1.2. CONSUMBALES

22.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)

22.4.1 BY PRODUCT

22.4.1.1. INSTRUMENTS

22.4.1.2. CONSUMBALES

22.5 DIAGNOSTIC LABORATORIES

22.5.1 BY PRODUCT

22.5.1.1. INSTRUMENTS

22.5.1.2. CONSUMBALES

22.6 HOSPITALS & CLINICAL TESTING LABS

22.6.1 BY PRODUCT

22.6.1.1. INSTRUMENTS

22.6.1.2. CONSUMBALES

22.7 CELL BANKS & BIOREPOSITORIES

22.7.1 BY PRODUCT

22.7.1.1. INSTRUMENTS

22.7.1.2. CONSUMBALES

22.8 GOVERNMENT & REGULATORY AGENCIES

22.8.1 BY PRODUCT

22.8.1.1. INSTRUMENTS

22.8.1.2. CONSUMBALES

22.9 OTHERS

23 GLOBAL CELL ANALYSIS MARKET, BY SALES CHANNEL

23.1 OVERVIEW

23.2 DIRECT TENDER

23.3 RETAIL SALES

23.3.1 OFFLINE

23.3.2 ONLINE

23.4 OTHERS

24 GLOBAL CELL ANALYSIS MARKET, BY GEOGRAPHY

GLOBAL CELL ANALYSIS MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

24.1 NORTH AMERICA

24.1.1 U.S.

24.1.2 CANADA

24.1.3 MEXICO

24.2 EUROPE

24.2.1 GERMANY

24.2.2 FRANCE

24.2.3 U.K.

24.2.4 ITALY

24.2.5 SPAIN

24.2.6 RUSSIA

24.2.7 TURKEY

24.2.8 BELGIUM

24.2.9 NETHERLANDS

24.2.10 SWITZERLAND

24.2.11 REST OF EUROPE

24.3 ASIA-PACIFIC

24.3.1 JAPAN

24.3.2 CHINA

24.3.3 SOUTH KOREA

24.3.4 INDIA

24.3.5 AUSTRALIA

24.3.6 SINGAPORE

24.3.7 THAILAND

24.3.8 MALAYSIA

24.3.9 INDONESIA

24.3.10 PHILIPPINES

24.3.11 REST OF ASIA-PACIFIC

24.4 SOUTH AMERICA

24.4.1 BRAZIL

24.4.2 ARGENTINA

24.4.3 PERU

24.4.4 CHILE

24.4.5 COLOMBIA

24.4.6 VENEZUELA

24.4.7 REST OF SOUTH AMERICA

24.5 MIDDLE EAST AND AFRICA

24.5.1 SOUTH AFRICA

24.5.2 SAUDI ARABIA

24.5.3 UAE

24.5.4 EGYPT

24.5.5 ISRAEL

24.5.6 REST OF MIDDLE EAST AND AFRICA

24.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

25 GLOBAL CELL ANALYSIS MARKET, COMPANY LANDSCAPE

25.1 COMPANY SHARE ANALYSIS: GLOBAL

25.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

25.3 COMPANY SHARE ANALYSIS: EUROPE

25.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

25.5 MERGERS & ACQUISITIONS

25.6 NEW PRODUCT DEVELOPMENT & APPROVALS

25.7 EXPANSIONS

25.8 REGULATORY CHANGES

25.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

26 GLOBAL CELL ANALYSIS MARKET, SWOT AND DBMR ANALYSIS

27 GLOBAL CELL ANALYSIS MARKET, COMPANY PROFILE

27.1 THERMO FISHER SCIENTIFIC INC.

27.1.1 COMPANY OVERVIEW

27.1.2 REVENUE ANALYSIS

27.1.3 GEOGRAPHIC PRESENCE

27.1.4 PRODUCT PORTFOLIO

27.1.5 RECENT DEVELOPEMENTS

27.2 BECTON, DICKINSON AND COMPANY

27.2.1 COMPANY OVERVIEW

27.2.2 REVENUE ANALYSIS

27.2.3 GEOGRAPHIC PRESENCE

27.2.4 PRODUCT PORTFOLIO

27.2.5 RECENT DEVELOPEMENTS

27.3 DANAHER CORPORATION

27.3.1 COMPANY OVERVIEW

27.3.2 REVENUE ANALYSIS

27.3.3 GEOGRAPHIC PRESENCE

27.3.4 PRODUCT PORTFOLIO

27.3.5 RECENT DEVELOPEMENTS

27.4 MERCK KGAA

27.4.1 COMPANY OVERVIEW

27.4.2 REVENUE ANALYSIS

27.4.3 GEOGRAPHIC PRESENCE

27.4.4 PRODUCT PORTFOLIO

27.4.5 RECENT DEVELOPEMENTS

27.5 AGILENT TECHNOLOGIES, INC.

27.5.1 COMPANY OVERVIEW

27.5.2 REVENUE ANALYSIS

27.5.3 GEOGRAPHIC PRESENCE

27.5.4 PRODUCT PORTFOLIO

27.5.5 RECENT DEVELOPEMENTS

27.6 BIO-RAD LABORATORIES, INC.

27.6.1 COMPANY OVERVIEW

27.6.2 REVENUE ANALYSIS

27.6.3 GEOGRAPHIC PRESENCE

27.6.4 PRODUCT PORTFOLIO

27.6.5 RECENT DEVELOPEMENTS

27.7 PERKINELMER, INC.

27.7.1 COMPANY OVERVIEW

27.7.2 REVENUE ANALYSIS

27.7.3 GEOGRAPHIC PRESENCE

27.7.4 PRODUCT PORTFOLIO

27.7.5 RECENT DEVELOPEMENTS

27.8 GE HEALTHCARE

27.8.1 COMPANY OVERVIEW

27.8.2 REVENUE ANALYSIS

27.8.3 GEOGRAPHIC PRESENCE

27.8.4 PRODUCT PORTFOLIO

27.8.5 RECENT DEVELOPEMENTS

27.9 ILLUMINA, INC.

27.9.1 COMPANY OVERVIEW

27.9.2 REVENUE ANALYSIS

27.9.3 GEOGRAPHIC PRESENCE

27.9.4 PRODUCT PORTFOLIO

27.9.5 RECENT DEVELOPEMENTS

27.1 ROCHE DIAGNOSTICS

27.10.1 COMPANY OVERVIEW

27.10.2 REVENUE ANALYSIS

27.10.3 GEOGRAPHIC PRESENCE

27.10.4 PRODUCT PORTFOLIO

27.10.5 RECENT DEVELOPEMENTS

27.11 PROMEGA CORPORATION

27.11.1 COMPANY OVERVIEW

27.11.2 REVENUE ANALYSIS

27.11.3 GEOGRAPHIC PRESENCE

27.11.4 PRODUCT PORTFOLIO

27.11.5 RECENT DEVELOPEMENTS

27.12 ABCAM PLC

27.12.1 COMPANY OVERVIEW

27.12.2 REVENUE ANALYSIS

27.12.3 GEOGRAPHIC PRESENCE

27.12.4 PRODUCT PORTFOLIO

27.12.5 RECENT DEVELOPEMENTS

27.13 MILTENYI BIOTEC

27.13.1 COMPANY OVERVIEW

27.13.2 REVENUE ANALYSIS

27.13.3 GEOGRAPHIC PRESENCE

27.13.4 PRODUCT PORTFOLIO

27.13.5 RECENT DEVELOPEMENTS

27.14 SARTORIUS AG

27.14.1 COMPANY OVERVIEW

27.14.2 REVENUE ANALYSIS

27.14.3 GEOGRAPHIC PRESENCE

27.14.4 PRODUCT PORTFOLIO

27.14.5 RECENT DEVELOPEMENTS

27.15 TECAN GROUP LTD.

27.15.1 COMPANY OVERVIEW

27.15.2 REVENUE ANALYSIS

27.15.3 GEOGRAPHIC PRESENCE

27.15.4 PRODUCT PORTFOLIO

27.15.5 RECENT DEVELOPEMENTS

27.16 CELL SIGNALING TECHNOLOGY, INC.

27.16.1 COMPANY OVERVIEW

27.16.2 REVENUE ANALYSIS

27.16.3 GEOGRAPHIC PRESENCE

27.16.4 PRODUCT PORTFOLIO

27.16.5 RECENT DEVELOPEMENTS

27.17 SYSMEX CORPORATION

27.17.1 COMPANY OVERVIEW

27.17.2 REVENUE ANALYSIS

27.17.3 GEOGRAPHIC PRESENCE

27.17.4 PRODUCT PORTFOLIO

27.17.5 RECENT DEVELOPEMENTS

27.18 OLYMPUS CORPORATION

27.18.1 COMPANY OVERVIEW

27.18.2 REVENUE ANALYSIS

27.18.3 GEOGRAPHIC PRESENCE

27.18.4 PRODUCT PORTFOLIO

27.18.5 RECENT DEVELOPMENTS.

27.19 TAKARA BIO INC.

27.19.1 COMPANY OVERVIEW

27.19.2 REVENUE ANALYSIS

27.19.3 GEOGRAPHIC PRESENCE

27.19.4 PRODUCT PORTFOLIO

27.19.5 RECENT DEVELOPEMENTS

27.2 AXION BIOSYSTEMS

27.20.1 COMPANY OVERVIEW

27.20.2 REVENUE ANALYSIS

27.20.3 GEOGRAPHIC PRESENCE

27.20.4 PRODUCT PORTFOLIO

27.20.5 RECENT DEVELOPEMENTS

27.21 EPPENDORF AG

27.21.1 COMPANY OVERVIEW

27.21.2 REVENUE ANALYSIS

27.21.3 GEOGRAPHIC PRESENCE

27.21.4 PRODUCT PORTFOLIO

27.21.5 RECENT DEVELOPEMENTS

27.22 BRUKER CORPORATION

27.22.1 COMPANY OVERVIEW

27.22.2 REVENUE ANALYSIS

27.22.3 GEOGRAPHIC PRESENCE

27.22.4 PRODUCT PORTFOLIO

27.22.5 RECENT DEVELOPEMENTS

27.23 QIAGEN N.V.

27.23.1 COMPANY OVERVIEW

27.23.2 REVENUE ANALYSIS

27.23.3 GEOGRAPHIC PRESENCE

27.23.4 PRODUCT PORTFOLIO

27.23.5 RECENT DEVELOPEMENTS

27.24 FLUIDIGM CORPORATION

27.24.1 COMPANY OVERVIEW

27.24.2 REVENUE ANALYSIS

27.24.3 GEOGRAPHIC PRESENCE

27.24.4 PRODUCT PORTFOLIO

27.24.5 RECENT DEVELOPEMENTS

27.25 BIO-TECHNE CORPORATION

27.25.1 COMPANY OVERVIEW

27.25.2 REVENUE ANALYSIS

27.25.3 GEOGRAPHIC PRESENCE

27.25.4 PRODUCT PORTFOLIO

27.25.5 RECENT DEVELOPEMENTS

27.26 CHARLES RIVER LABORATORIES

27.26.1 COMPANY OVERVIEW

27.26.2 REVENUE ANALYSIS

27.26.3 GEOGRAPHIC PRESENCE

27.26.4 PRODUCT PORTFOLIO

27.26.5 RECENT DEVELOPEMENTS

27.27 LUMINEX CORPORATION

27.27.1 COMPANY OVERVIEW

27.27.2 REVENUE ANALYSIS

27.27.3 GEOGRAPHIC PRESENCE

27.27.4 PRODUCT PORTFOLIO

27.27.5 RECENT DEVELOPEMENTS

27.28 SONY BIOTECHNOLOGY INC.

27.28.1 COMPANY OVERVIEW

27.28.2 REVENUE ANALYSIS

27.28.3 GEOGRAPHIC PRESENCE

27.28.4 PRODUCT PORTFOLIO

27.28.5 RECENT DEVELOPEMENTS

28 CONCLUSION

29 QUESTIONNAIRE

30 ABOUT DATA BRIDGE MARKET RESEARCH

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Cell Analysis Market is projected to grow at a CAGR of 7.9% during the forecast period by 2030.
The future market value of the Cell Analysis Market is expected to reach USD 33.82 billion by 2030.
The major players in the Cell Analysis Market are Danaher (U.S.), Thermo Fisher Scientific Inc. (U.S.), BD (U.S.), General Electric (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc (U.S.), Olympus Corporation (Japan), Promega Corporation (U.S.), etc.
The countries covered in the Cell Analysis Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, etc.
Testimonial